Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The identifier "compound 14c" is a non-specific code name used across numerous independent research studies to refer to a variety of distinct experimental small molecules. These compounds exhibit diverse mechanisms of action and are being investigated for a wide range of therapeutic applications, including antibacterial, antifungal, antiviral, anticancer, anti-inflammatory, antileishmanial, and neuroprotective effects, as well as for hypertension. Due to its non-specific nature, "compound 14c" does not refer to a single drug but rather to multiple unique chemical entities synthesized and evaluated in different contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on compound 14c.